Click a link below to view the mailing archive as if it had been sent to you.
| 2024-07-31 12:15 | | GSK shares fall after sales of top two vaccines disappoint and more... |
| 2024-07-31 00:15 | | Vertex gets January 30 decision date for non-opioid pain med suzetrigine and more... |
| 2024-07-30 12:15 | | Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs and more... |
| 2024-07-30 00:15 | | VC dollars pour into biopharma, with Q2 haul signaling sunshine ahead and more... |
| 2024-07-29 12:15 | | GSK becomes Flagship's latest partner in $7B biobucks respiratory, immunology pact and more... |
| 2024-07-26 12:15 | | Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe and more... |
| 2024-07-26 00:15 | | Roche says it’ll move quickly with ‘differentiated’ obesity drugs and more... |
| 2024-07-25 12:15 | | Trials to watch: Four biologics concluding pivotal COPD trials and more... |
| 2024-07-25 00:15 | | Novartis hopes for better luck with bispecifics via $150M upfront Dren Bio deal and more... |
| 2024-07-24 12:15 | | Merck, Rapt, Aslan and more cut staff and more... |
| 2024-07-24 00:15 | | BeiGene debuts $800M biologics plant set to create ‘hundreds’ of jobs in New Jersey and more... |
| 2024-07-23 12:15 | | Merck claims late-stage study success for RSV antibody and more... |
| 2024-07-23 00:15 | | US government declines to clear Bluebird fertility support for Zynteglo patients and more... |
| 2024-07-22 12:15 | | Vermont latest state to sue PBMs for allegedly driving up drug prices and more... |
| 2024-07-22 00:15 | | Where 3 Democrats who could replace Biden atop the ticket stand on health care and more... |
| 2024-07-20 00:15 | | Abbott plans marketing push for glucose monitors beyond diabetes |
| 2024-07-19 12:15 | | Bayer eyes Nubeqa’s label expansion in prostate cancer following Phase III win and more... |
| 2024-07-19 00:15 | | ‘Not prudent’ for Novartis to join GLP-1 obesity race as late-runner, says CEO and more... |
| 2024-07-18 12:15 | | Despite layoff announcements, Novartis beats Q2 expectations and more... |
| 2024-07-18 00:15 | | Nvidia, Pfizer lead $80 mln funding for Israeli medical AI tech firm CytoReason and more... |
| 2024-07-17 12:15 | | To Weather Layoffs, Biotechs Must Guard Against Lawsuits and more... |
| 2024-07-17 00:15 | | Cardurion raises another $260M to fuel heart drug pipeline and more... |
| 2024-07-16 12:15 | | Johnson & Johnson proposes $505M settlement with bankrupt talc miners and more... |
| 2024-07-16 00:15 | | Amylyx Purchases Investigational GLP-1 Drug Avexitide in Auction Deal for $35 Million and more... |
| 2024-07-15 12:15 | | 5 Neuro Data Readouts to Watch in the Second Half of 2024 and more... |
| 2024-07-15 00:15 | | Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market and more... |
| 2024-07-12 12:15 | | AbbVie’s Humira continues to lose market share as biosimilars gain ground and more... |
| 2024-07-12 00:15 | | Biotech investors remain cautious in a stabilizing funding environment and more... |
| 2024-07-11 12:15 | | Pfizer moves forward with once-daily version of weight loss pill after setbacks and more... |
| 2024-07-11 00:15 | | Illumina buys Fluent Biosciences, adding single-cell analysis tech and more... |
| 2024-07-10 12:15 | | 2024's layoff woes continue in Q2 and more... |
| 2024-07-10 00:15 | | Medical marketers need to bridge gap between different generations of HCPs and more... |
| 2024-07-09 12:15 | | The battle over J&J’s bankruptcy plan to end talc lawsuits and more... |
| 2024-07-09 00:15 | | Roche to reintroduce eye implant med Susvimo 2 years after recall and more... |
| 2024-07-08 12:15 | | Lilly inks $3.2B Morphic buyout to snag oral rival to Takeda's IBD blockbuster and more... |
| 2024-07-03 12:15 | | Sanofi and Regeneron's Dupixent scores in Europe as the first biologic to treat COPD and more... |
| 2024-07-03 00:15 | | Eli Lilly Alzheimer's drug approved by US FDA |
| 2024-07-02 12:15 | | Moderna receives $176 million from BARDA for mRNA influenza vaccines and more... |
| 2024-07-02 00:15 | | Departing FDA staffers told they can still influence the agency in Big Pharma jobs: BMJ report and more... |
| 2024-07-01 12:15 | | Gilead’s Trodelvy stumbles in late-stage trials but remains prized cancer asset and more... |
| 2024-07-01 00:15 | | FDA Rejects Rocket’s Gene Therapy, Cites Need for Additional CMC Info and more... |
